Department of Nephrology, the 306th Hospital of Chinese PLA, 9 AnXiangBeiLi Road, Beijing, 100101, China.
Department of Nephrology, The Hospital of Shunyi District Beijing, No.3 Guangming South Street, Shunyi District, Beijing, China.
Am J Cardiovasc Drugs. 2018 Oct;18(5):373-386. doi: 10.1007/s40256-018-0274-3.
To date, universally accepted preventive measures for contrast-induced acute kidney injury (CI-AKI) do not exist, and they warrant further research.
The purpose of this study was to evaluate the efficacy of vitamins, including vitamin C and E, for prevention of CI-AKI.
We electronically searched the MEDLINE, EMBASE, and Cochrane databases. The outcome of interest was the incidence of CI-AKI.
A total of 19 studies were included in this meta-analysis. Pooled analysis showed that vitamin C plus saline [relative risk (RR) = 0.63, 95% confidence interval (CI) 0.49-0.82, p = 0.0005] and vitamin E plus saline (RR = 0.39, 95% CI 0.24-0.62, p < 0.0001) significantly reduced the incidence of CI-AKI compared to saline alone. The effect of vitamin C plus saline was further confirmed by trial sequential analysis (TSA). However, TSA indicated that more trials are required to confirm the efficacy of vitamin E plus saline. There was no significant difference in preventing CI-AKI between vitamin C and N-acetylcysteine (NAC) (RR = 0.90, 95% CI 0.47-1.71, p = 0.75), between vitamin C plus NAC and saline (RR = 0.62, 95% CI 0.30-1.30, p = 0.20), as well as between vitamin C plus NAC and NAC (RR = 0.97, 95% CI 0.49-1.92, p = 0.93).
Vitamin C plus saline administration is effective at reducing the risk of CI-AKI. Evidence for the use of vitamin E plus saline in this context is encouraging, but more trials are required. Furthermore, this meta-analysis and TSA indicated insufficient power to draw a definitive conclusion on the effect of vitamin C plus NAC, versus saline or NAC alone, which needs to be explored further.
目前,尚无被普遍认可的预防对比剂诱导急性肾损伤(CI-AKI)的措施,因此需要进一步研究。
本研究旨在评估维生素(包括维生素 C 和 E)预防 CI-AKI 的效果。
我们对 MEDLINE、EMBASE 和 Cochrane 数据库进行了电子检索。主要结局指标为 CI-AKI 的发生率。
共有 19 项研究纳入本荟萃分析。汇总分析显示,维生素 C 联合生理盐水[相对风险(RR)=0.63,95%置信区间(CI)0.49-0.82,p=0.0005]和维生素 E 联合生理盐水(RR=0.39,95%CI 0.24-0.62,p<0.0001)与单独使用生理盐水相比,CI-AKI 的发生率显著降低。试验序贯分析(TSA)进一步证实了维生素 C 联合生理盐水的效果。但是,TSA 提示需要更多的试验来证实维生素 E 联合生理盐水的疗效。维生素 C 与 N-乙酰半胱氨酸(NAC)(RR=0.90,95%CI 0.47-1.71,p=0.75)、维生素 C 联合 NAC 与生理盐水(RR=0.62,95%CI 0.30-1.30,p=0.20)以及维生素 C 联合 NAC 与 NAC(RR=0.97,95%CI 0.49-1.92,p=0.93)预防 CI-AKI 的效果无显著差异。
给予维生素 C 联合生理盐水可降低 CI-AKI 的风险。在这种情况下,使用维生素 E 联合生理盐水的证据令人鼓舞,但还需要更多的试验。此外,本荟萃分析和 TSA 提示,目前尚无法确定维生素 C 联合 NAC 与单独使用生理盐水或 NAC 相比的效果,需要进一步探讨。